Clearmind submits FDA recommendations on psychedelic therapies
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
What is pneumonic plague and how dangerous is it?
A 28-year-old lab researcher at a Russian institute dedicated to studying plague and dangerous pathogens died of pneumonia of an “unknown” origin.
Ten people linked to Kenya's first-ever Ebola case quarantined as screening concerns grow
The patient passed through multiple cities in DR Congo, drove to Uganda and eventually flew to Kenya.
Highmark Health taps Karen Hanlon as CEO
Hanlon, who has worked in a variety of leadership roles at Highmark during nearly three decades with the company, will be the organization’s first-ever woman CEO.